OPDUALAG NIVOLUMAB/RELATLIMAB)
Mark Identification

OPDUALAG NIVOLUMAB/RELATLIMAB)

Serial Number

88805781

Filing Date

Feb 21, 2020

Trademark by

BRISTOL-MYERS SQUIBB COMPANY

Classification Information

Pharmaceutical preparations for human use for the treatment and prevention of cancer, all of the foregoing comprising monoclonal antibodies

Pharmaceuticals

Health care services, namely, providing information to physicians, health care professionals and patients on the topic of health issues, health awareness and pharmaceuticals; Providing a website featuring educational information in the field of healthcare and pharmaceutical preparations; all of the foregoing involving monoclonal antibodies

Medical, Beauty & Agricultural